Larry C. Ford

491 total citations
28 papers, 391 citations indexed

About

Larry C. Ford is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Larry C. Ford has authored 28 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Oncology. Recurrent topics in Larry C. Ford's work include Reproductive tract infections research (4 papers), Surgical site infection prevention (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Larry C. Ford is often cited by papers focused on Reproductive tract infections research (4 papers), Surgical site infection prevention (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Larry C. Ford collaborates with scholars based in United States. Larry C. Ford's co-authors include Leo D. Lagasse, Robert J. DeLange, Thomas B. Lebherz, Neville F. Hacker, James D. Hoeschele, Jonathan S. Berek, D. Friday King, Victor D. Newcomer, Edmund S. Petrilli and J. S. Berek and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Obstetrics and Gynecology and Fertility and Sterility.

In The Last Decade

Larry C. Ford

28 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry C. Ford United States 12 112 96 80 77 53 28 391
Coulam Cb United States 10 58 0.5× 81 0.8× 88 1.1× 132 1.7× 51 1.0× 18 432
James C. Caillouette United States 7 76 0.7× 66 0.7× 65 0.8× 59 0.8× 11 0.2× 15 371
W. Eppel Austria 13 150 1.3× 28 0.3× 169 2.1× 71 0.9× 137 2.6× 30 494
A. B. Maclean United Kingdom 10 213 1.9× 78 0.8× 219 2.7× 67 0.9× 44 0.8× 18 550
Fletcher C. Derrick United States 13 158 1.4× 248 2.6× 29 0.4× 96 1.2× 32 0.6× 39 530
William F. Tarry United States 14 204 1.8× 19 0.2× 81 1.0× 101 1.3× 93 1.8× 30 653
Daiki Ogishima Japan 9 42 0.4× 164 1.7× 76 0.9× 94 1.2× 114 2.2× 26 402
P Stentella Italy 10 100 0.9× 22 0.2× 173 2.2× 16 0.2× 41 0.8× 30 330
David M. Drylie United States 11 98 0.9× 75 0.8× 126 1.6× 38 0.5× 12 0.2× 26 377
Yuri Hanada United States 11 103 0.9× 13 0.1× 59 0.7× 17 0.2× 16 0.3× 25 339

Countries citing papers authored by Larry C. Ford

Since Specialization
Citations

This map shows the geographic impact of Larry C. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry C. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry C. Ford more than expected).

Fields of papers citing papers by Larry C. Ford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry C. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry C. Ford. The network helps show where Larry C. Ford may publish in the future.

Co-authorship network of co-authors of Larry C. Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Larry C. Ford. A scholar is included among the top collaborators of Larry C. Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry C. Ford. Larry C. Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ford, Larry C., Jakob Nilsson, & Hunter A. Hammill. (1988). Effects of cefotetan disodium, cefoxitin, cefazolin, and cefotaxime in vitro on polymorphonuclear leukocytes from patients with leukopenia and severe pelvic inflammatory disease. American Journal of Obstetrics and Gynecology. 158(3). 744–745. 2 indexed citations
3.
Ford, Larry C., et al.. (1987). Cost-effective use of antibiotic prophylaxis for cesarean section. American Journal of Obstetrics and Gynecology. 157(2). 506–510. 11 indexed citations
4.
Ford, Larry C.. (1986). Antibiotic considerations in the United States of America. Journal of Obstetrics and Gynaecology. 6(sup1). S9–S10. 1 indexed citations
5.
Simon, James A., Ingrid A. Rodi, Paul G. Stumpf, et al.. (1986). Polysiloxane vaginal rings and cylinders for physiologic endometrial priming in functionally agonadal women. Fertility and Sterility. 46(4). 619–625. 12 indexed citations
6.
Ford, Larry C., Khalil Tabsh, & Thomas B. Lebherz. (1986). Use of antibiotics for prophylaxis with caesarean section. Journal of Obstetrics and Gynaecology. 6(sup1). S68–S70. 1 indexed citations
7.
Ford, Larry C.. (1986). Cost of Antibiotic Prophylaxis in Cesarean Section. Drug Intelligence & Clinical Pharmacy. 20(7-8). 592–593. 4 indexed citations
8.
Benigno, Benedict B., J Evrard, S Faro, et al.. (1986). A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy.. PubMed. 163(5). 421–7. 9 indexed citations
9.
Ford, Larry C., et al.. (1985). Antiandrogen and Antineoplastic Effects of a Novel Drug, CPC10997. Chemotherapy. 31(5). 362–365. 3 indexed citations
10.
Hammill, Hunter A., W.E. Owens, Larry C. Ford, & Sydney M. Finegold. (1984). A Rat Model of Unilateral Utero-Tubo-Ovarian Abscess. Clinical Infectious Diseases. 6(Supplement_1). S96–S100. 5 indexed citations
11.
Hacker, Neville F., et al.. (1983). Pharmacokinetics of Ip cisplatin in refractory ovarian carcinoma.. PubMed. 67(12). 1085–92. 58 indexed citations
12.
Lebherz, Thomas B., et al.. (1983). A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use.. PubMed. 5(4). 409–16. 4 indexed citations
13.
Ford, Larry C., et al.. (1983). Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulva. Gynecologic Oncology. 15(1). 27–31. 37 indexed citations
14.
Ford, Larry C., et al.. (1983). Evaluation of postpartum culture techniques. Journal of Obstetrics and Gynaecology. 4(2). 97–100. 3 indexed citations
15.
Ford, Larry C., D. Friday King, Leo D. Lagasse, & Victor D. Newcomer. (1983). Increased Androgen Binding in Keloids: A Preliminary Communication. The Journal of Dermatologic Surgery and Oncology. 9(7). 545–547. 41 indexed citations
16.
Lebherz, Thomas B. & Larry C. Ford. (1982). Candida albicans Vaginitis: The Problem Is Diagnosis, the Enigma Is Treatment. Chemotherapy. 28(1). 73–79. 6 indexed citations
17.
Ford, Larry C., et al.. (1981). Identification of leukin in amniotic fluid. Journal of Obstetrics and Gynaecology. 1(3). 162–166. 3 indexed citations
18.
Ford, Larry C., et al.. (1981). Identification of β-lysin as a zinc-dependent antibacterial protein in amniotic fluid. Journal of Obstetrics and Gynaecology. 2(2). 79–84. 11 indexed citations
19.
Ford, Larry C., Samuel C. Ballon, Leo D. Lagasse, & Robert J. DeLange. (1980). Relative concentrations of human chorionic gonadotropin, human placental lactogen, and α-fetoprotein in the serum and cerebrospinal fluid of pregnant patients at term☆. Gynecologic Oncology. 10(1). 26–31. 1 indexed citations
20.
Ford, Larry C., et al.. (1968). Protection of Mice by Postirradiation Treatment with a Cell-Free Component of Spleen. Experimental Biology and Medicine. 127(1). 286–289. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Coulam Cb Breakdown of academic impact, for papers by James C. Caillouette Breakdown of academic impact, for papers by W. Eppel Breakdown of academic impact, for papers by A. B. Maclean Breakdown of academic impact, for papers by Fletcher C. Derrick Breakdown of academic impact, for papers by William F. Tarry Breakdown of academic impact, for papers by Daiki Ogishima Breakdown of academic impact, for papers by P Stentella Breakdown of academic impact, for papers by David M. Drylie Breakdown of academic impact, for papers by Yuri Hanada
Rankless by CCL
2026